Covered medications: all formulations of Wegovy (semaglutide), including both the once-weekly injection and the oral 25 mg tablet
In particular, further evidence is needed to establish the effective role of nutraceutical supplementation in combination with specific, targeted dietary interventions, as current studies have not investigated this potential synergistic effect
Brown, N., Martin, D., Waldron, M., et al
Curr Diabetes Rev 16:313326
In other words, evidence from a few studies suggests that GLP-1-agonist-induced weight loss may lead to expected levels of muscle loss while improving muscle quality, but further research is needed
Bundling these services into one package helps patients avoid unexpected add-on charges and better understand their total cost from the start